The NDA for SPN-830 is supported by data from an extensive development program that includes the phase 3 TOLEDO study and a supportive open-label study. The New Drug Application (NDA) for SPN-830 ...
Indian clinical trial data for drugs like safinamide and apomorphine pump therapy are key for global pharma to seek US FDA approval. This along with specific therapies like gene based treatments ...
Patients should receive training on the proper use of the delivery device prior to starting treatment. The Food and Drug Administration (FDA) has approved Onapgo™ (apomorphine hydrochloride [HCl]) for ...
SALZBURG, Austria--(BUSINESS WIRE)--Launched as the D-mine ® Pump, this portable micro infusion device recently received European CE approval and is currently being launched in several European ...
Ignis Therapeutics, an innovative life science company, and STADA’s Britannia Pharmaceuticals Ltd. (Britannia) affiliate jointly announced that two companies have signed an exclusive licensing ...
India has begun a new, promising era in Parkinson's disease treatment, as new therapies and scientific advances now start to transform the way the condition is treated. From the availability of drug ...